People: Celgene Corp (CELG.O)

CELG.O on Nasdaq

94.78USD
30 Sep 2014
Price Change (% chg)

$-0.86 (-0.90%)
Prev Close
$95.64
Open
$95.39
Day's High
$96.00
Day's Low
$93.73
Volume
4,362,781
Avg. Vol
4,335,624
52-wk High
$96.50
52-wk Low
$66.85

Search Stocks

Cox, Carrie 

Brief Biography

Ms. Carrie S. Cox is an Independent Director of Celgene Corp. She is a member of the Audit Committee since March 2010. Ms. Cox currently serves as the Chairman of the Board of Directors and Chief Executive Officer of Humacyte, Inc., a privately-held regenerative medicine company primarily focused in developing products for vascular disease and for therapeutic filling and soft tissue repair. Ms. Cox served as Executive Vice President of Schering-Plough and President of Schering-Plough’s Global Pharmaceutical Business until November 3, 2009 when Schering-Plough merged with Merck & Co., Inc. Prior to joining Schering-Plough, Ms. Cox served as President of Pharmacia Corporation’s pharmaceutical business until its merger with Pfizer Inc. in 2003. Ms. Cox is a member of the Board of Directors of Texas Instruments and has served on their audit and compensation committees, and has been appointed to the Board of Directors of Cardinal Health, Inc. Ms. Cox is also a member of the Harvard School of Public Health’s Health Policy and Management Executive Council and a member of the Board of Overseers of the University of Pennsylvania Museum of Archaeology and Anthropology. Ms. Cox is a graduate of the Massachusetts College of Pharmacy.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Hugin

20,995,800

Mark Alles

7,502,700

Peter Kellogg

--

Jacqualyn Fouse

7,795,940

Tuomo Patsi

--

Scott Smith

--
As Of 30 Dec 2013
Search Stocks